Literature DB >> 15943762

Oral and vaginal epithelial cell anti-Candida activity is acid labile and does not require live epithelial cells.

J Yano1, E A Lilly, C Steele, D Fortenberry, P L Fidel.   

Abstract

BACKGROUND: Candida albicans is the causative agent of oral and vaginal candidiasis. Innate host defenses against C. albicans are important against each infection. Among these are oral and vaginal epithelial cells that have anti-Candida activity. The mechanism of action includes a requirement for cell contact with no role for soluble factors, and a putative role for carbohydrates based on the sensitivity of the activity to periodic acid.
METHODS: Periodic acid treatment of epithelial cells as well as the property of partial resistance of antifungal activity to fixation was used to further dissect the mechanism of action.
RESULTS: The results herein effectively now challenge a role for carbohydrates alone. Firstly, the putative carbohydrate(s) released into supernatants of periodic acid-treated epithelial cells could not compete with fresh epithelial cells for activity, and equivalent abrogation of activity was observed by periodic acid-treated cells irrespective of the amount of carbohydrate released. Instead, the similar abrogation of activity following treatment with other acids or when cocultured under acidic conditions suggests that the activity is acid-labile. Finally, while activity requires intact epithelial cells, it does not require live cells; activity was minimally affected by fixing epithelial cells prior to coculture where the majority of cells remained impermeable to Trypan blue but were defined as non-viable by positive nuclear staining with propidium iodide.
CONCLUSION: These results suggest that antifungal activity is dependent on contact by intact, but not necessarily live, epithelial cells through an acid-labile mechanism.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15943762      PMCID: PMC1361270          DOI: 10.1111/j.1399-302X.2005.00212.x

Source DB:  PubMed          Journal:  Oral Microbiol Immunol        ISSN: 0902-0055


  13 in total

1.  Growth inhibition of Candida by human oral epithelial cells.

Authors:  C Steele; J Leigh; R Swoboda; P L Fidel
Journal:  J Infect Dis       Date:  2000-10-09       Impact factor: 5.226

2.  Effects of reproductive hormones on experimental vaginal candidiasis.

Authors:  P L Fidel; J Cutright; C Steele
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

3.  Generation of papillomavirus-immortalized cell lines from normal human ectocervical, endocervical, and vaginal epithelium that maintain expression of tissue-specific differentiation proteins.

Authors:  R N Fichorova; J G Rheinwald; D J Anderson
Journal:  Biol Reprod       Date:  1997-10       Impact factor: 4.285

4.  Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome.

Authors:  R S Klein; C A Harris; C B Small; B Moll; M Lesser; G H Friedland
Journal:  N Engl J Med       Date:  1984-08-09       Impact factor: 91.245

5.  Growth inhibition of Candida albicans by vaginal cells from naïve mice.

Authors:  C Steele; H Ozenci; W Luo; M Scott; P L Fidel
Journal:  Med Mycol       Date:  1999-08       Impact factor: 4.076

6.  Vaginal and oral epithelial cell anti-Candida activity.

Authors:  Fatema Nomanbhoy; Chad Steele; Junko Yano; Paul L Fidel
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

7.  Differential susceptibility of two species of macaques to experimental vaginal candidiasis.

Authors:  C Steele; M Ratterree; P L Fidel
Journal:  J Infect Dis       Date:  1999-09       Impact factor: 5.226

8.  Pathogenesis of Recurrent Vulvovaginal Candidiasis.

Authors:  Jack D. Sobel
Journal:  Curr Infect Dis Rep       Date:  2002-12       Impact factor: 3.725

Review 9.  Pathogenesis and treatment of recurrent vulvovaginal candidiasis.

Authors:  J D Sobel
Journal:  Clin Infect Dis       Date:  1992-03       Impact factor: 9.079

10.  Vaginal yeast colonisation, prevalence of vaginitis, and associated local immunity in adolescents.

Authors:  M M Barousse; B J Van Der Pol; D Fortenberry; D Orr; P L Fidel
Journal:  Sex Transm Infect       Date:  2004-02       Impact factor: 3.519

View more
  13 in total

Review 1.  Candida-host interactions in HIV disease: implications for oropharyngeal candidiasis.

Authors:  P L Fidel
Journal:  Adv Dent Res       Date:  2011-04

2.  Candida-induced oral epithelial cell responses.

Authors:  E A Lilly; J E Leigh; S H Joseph; P L Fidel
Journal:  Mycopathologia       Date:  2006-07       Impact factor: 2.574

Review 3.  Cytokines in the host response to Candida vaginitis: Identifying a role for non-classical immune mediators, S100 alarmins.

Authors:  Junko Yano; Mairi C Noverr; Paul L Fidel
Journal:  Cytokine       Date:  2011-12-17       Impact factor: 3.861

4.  Annexin-A1 identified as the oral epithelial cell anti-Candida effector moiety.

Authors:  E A Lilly; J Yano; P L Fidel
Journal:  Mol Oral Microbiol       Date:  2010-08       Impact factor: 3.563

5.  Role for dendritic cells in immunoregulation during experimental vaginal candidiasis.

Authors:  Dana M LeBlanc; Melissa M Barousse; Paul L Fidel
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

6.  Epithelial cell-derived S100 calcium-binding proteins as key mediators in the hallmark acute neutrophil response during Candida vaginitis.

Authors:  Junko Yano; Elizabeth Lilly; Melissa Barousse; Paul L Fidel
Journal:  Infect Immun       Date:  2010-09-07       Impact factor: 3.441

7.  Vaginal epithelial cell anti-Candida albicans activity is associated with protection against symptomatic vaginal candidiasis.

Authors:  Melissa M Barousse; Terri Espinosa; Kathleen Dunlap; Paul L Fidel
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

8.  Cervical mucins carry alpha(1,2)fucosylated glycans that partly protect from experimental vaginal candidiasis.

Authors:  Steven E Domino; Elizabeth A Hurd; Kristina A Thomsson; David M Karnak; Jessica M Holmén Larsson; Elisabeth Thomsson; Malin Bäckström; Gunnar C Hansson
Journal:  Glycoconj J       Date:  2009-12       Impact factor: 2.916

Review 9.  Immune defence mechanisms and immunoenhancement strategies in oropharyngeal candidiasis.

Authors:  Cristina Cunha Villar; Anna Dongari-Bagtzoglou
Journal:  Expert Rev Mol Med       Date:  2008-10-13       Impact factor: 5.600

Review 10.  Interactions of Candida albicans with epithelial cells.

Authors:  Weidong Zhu; Scott G Filler
Journal:  Cell Microbiol       Date:  2009-11-16       Impact factor: 3.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.